Finance

Lists
Q3 2026 earnings • released • EPS beat +2,32% • Revenue miss -0,16%
See results
ALC:NYSE
Alcon AG
71,83 USD
-0,86%
(-0,62) 1D
71,70 USD
-0,18% (-0,13)
After hours
Closed: 12-ноя., 16:00:04 GMT-5  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for ALC...
Open
73,06 USD
High
73,96 USD
Low
71,64 USD
Mkt. cap
30,41 млд
Avg. vol.
2,08 млн
Volume
2,25 млн
52-wk high
87,64 USD
52-wk low
61,84 USD
Beta
0,87
Shares outstanding
483,40 млн
No. of employees
25 миң
Open
73,06 USD
High
73,96 USD
Low
71,64 USD
Mkt. cap
30,41 млд
Avg. vol.
2,08 млн
Volume
2,25 млн
52-wk high
87,64 USD
52-wk low
61,84 USD
Beta
0,87
Shares outstanding
483,40 млн
No. of employees
25 миң
News stories
From web sources and news partners
Profile
Alcon Inc. is a Swiss-American pharmaceutical and medical device company specializing in eye care products. Alcon is incorporated in the Canton of Fribourg, Switzerland, and its global headquarters are located in Geneva, but its main operational base is in Fort Worth, Texas, United States, where it employs about 4,500 people. Alcon was a subsidiary of Novartis until April 2019, when it was spun out into a separate publicly traded company. Alcon itself has a number of subsidiaries, including Aerie Pharmaceuticals, focused on therapies for glaucoma and other diseases of the eye, and WaveLight, which develops and manufactures laser eye surgery technologies. Wikipedia
About Alcon AG
CEODavid J. Endicott
Employees25 миң
Founded1945
HeadquartersЖенева, Женева, Швейцария
SectorHealth Care
IndustryMedical device
Websitealcon.com
Analyst
Recommendation
Action
Price target
Projected
Date
No analyst ratings found.
Last report
2026-ж., 11-ноя.
Fiscal period
Q3 2026
0,91 USD / 0,89 USD
+2,32%beat
Revenue / Est. (USD)
2,74 млд / 2,74 млд
-0,16%miss
Fiscal Q3 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
2025-ж. дек.
2026-ж. мар.
2026-ж. июн.
2026-ж. сен.
Revenue
2,72 млд
2,71 млд
2,82 млд
2,74 млд
Cost of goods sold
1,20 млд
1,14 млд
1,15 млд
-
Cost of revenue
1,20 млд
1,14 млд
1,15 млд
-
Research and development expenses
273,00 млн
245,00 млн
261,00 млн
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
901,00 млн
882,00 млн
964,00 млн
-
Operating expense
1,20 млд
1,23 млд
1,26 млд
-
Total operating expenses
2,40 млд
2,38 млд
2,41 млд
-
Operating income
318,00 млн
330,00 млн
413,00 млн
-
Other non operating income
-28,00 млн
-
-
1,00 млн
EBT including unusual items
264,00 млн
240,00 млн
-46,00 млн
-
EBT excluding unusual items
271,00 млн
278,00 млн
356,00 млн
-
Income tax expense
47,00 млн
51,00 млн
-46,00 млн
-
Effective tax rate
17,80%
21,25%
100,00%
-
Other operating expenses
26,00 млн
106,00 млн
37,00 млн
-
Net income
217,00 млн
189,00 млн
-
-
Net profit margin
7,98%
6,98%
-
-
Earnings per share
0,78
0,85
0,84
0,91
Interest and investment income
74,00 млн
2,00 млн
-
-
Interest expense
-53,00 млн
-52,00 млн
-53,00 млн
-
Net interest expenses
21,00 млн
-50,00 млн
-53,00 млн
-
Depreciation and amortization charges
-
-
-
-
EBITDA
441,00 млн
600,00 млн
676,00 млн
-
Gain or loss from assets sale
9,00 млн
2,00 млн
2,00 млн
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
Upcoming events
AI content may include mistakes. Learn more
Google колдонмолору